Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-HER2 antibody are both extended with the scFv fragment from an anti-HER3 antibody. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY